drugset / Trial / NCT00247507

The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients

NCT00247507

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The aim of this study is to explore and identify the effects of acetylcysteine, a common mucolytic with anti-oxidant property, on alleviating the damage caused by increased oxidative stress in hemodialysis patients.

Timeline

Start
2005-09
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule